Details for New Drug Application (NDA): 216726
✉ Email this page to a colleague
The generic ingredient in SUCRALFATE is sucralfate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the sucralfate profile page.
Summary for 216726
Tradename: | SUCRALFATE |
Applicant: | Abon Pharms Llc |
Ingredient: | sucralfate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 216726
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 1GM/10ML | ||||
Approval Date: | Mar 21, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription